BHIVA-BASHH Position Statement on PrEP in the UK (second update May 2016) http://www.bhiva.org/positionStatements.aspx The Position Statement was revised following an NHS England update on the commissioning and provision of pre-exposure prophylaxis (PrEP) for HIV prevention (https://www.england.nhs.uk/2016/03/prep) TESTING ...
Latest News
10th December 2015
PROUD Results Key Messages and Q&A PROUD Study Key Messages, Q&A and further HIV PrEP trial information World AIDS Day announcement 1 December 2015 On this World AIDS Day of 2015 we can celebrate a year of major successes in HIV prevention. Last week the French Ministry of Health was the first in Europe to authorise access to PrEP for populations most at risk of HIV ...
PROUD results published showing pre-exposure prophylaxis effectively prevents HIV
10 September 2015 Results from the PROUD study, showing a daily pill can effectively protect people from HIV infection, were published today in The Lancet. PROUD is the first study of the pre-exposure prophylaxis approach to preventing HIV to be carried out in the UK. The results show the approach could play a major role in reducing the number of new infections among men who h ...
PrEP can be purchased from a pharmacy with a private prescription from a registered medical professional.
Purchasing pharmaceuticals only from pharmacies registered with the General Pharmaceutical Council (GPhC) will help consumers to avoid counterfeit medicines. All pharmacies in Great Britain, including those providing interest services, must be registered with the GPhC. The GPhC operates an internet pharmacy logo scheme to identify legitimate online pharmacies so that the pu ...
The PROUD study today reported that PrEP reduced the risk of HIV infection by 86% for gay and other men who have sex with men when delivered in sexual health clinics in England.
The PROUD study measured the effectiveness of daily PrEP for gay and other men who have sex with men in England. The results released at the Conference on Retroviruses and Opportunistic Infections today indicate that PrEP is highly protective for this group, reducing the risk of infection by 86%. The researchers concluded that PrEP offers a major opportunity to curb new HIV in ...
PROUD
MRC Clinical Trials Unit at UCL
90 High Holborn
London
WC1V 6LJ
Email: mrcctu.trial-proud@ucl.ac.uk